ALMB-0168, a novel Cx43 hemichannel agonist monoclonal antibody, for metastatic or unresectable osteosarcoma after standard chemotherapy: A multicenter, open-label, single-arm, phase 1 study

被引：0
|
作者：
Shen, Jingnan
Guo, Wei
Wang, Jin
Xie, Xianbiao
Xie, Lu
Xu, Jie
Jing, Chen
Lin, Jianhua
Li, Xianan
Zhou, Yong
Wang, Guowen
Zhang, Xiaojing
Yao, Weitao
Dong, Yang
Ye, Zhaoming
Wang, Li
Zeng, Yanyan
Wu, Yongyong
Yang, Xiugao
Zhang, Yanfeng
机构：
[1] Sun Yat Sen Univ, Dept Musculoskeletal Oncol, Affiliated Hosp 1, Guangzhou, Peoples R China
[2] Peking Univ, Peoples Hosp, Beijing, Peoples R China
[3] Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China
[4] Sun Yat sen Univ, Dept Musculoskeletal, Affiliated Hosp 1, Oncol Ctr, Guangzhou, Peoples R China
[5] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Canc Ctr, Wuhan, Peoples R China
[6] Fujian Med Univ, Dept Orthoped, Affiliated Hosp 1, Fuzhou, Peoples R China
[7] Hunan Canc Hosp, Changsha, Peoples R China
[8] Sichuan Univ, West China Hosp, Dept Orthoped, Chengdu, Peoples R China
[9] Tianjin Med Univ, Canc Inst & Hosp, Tianjin, Peoples R China
[10] Liaoning Canc Hosp & Inst, Shenyang, Peoples R China
[11] Zhengzhou Univ, Henan Canc Hosp, Dept Orthoped, Affiliated Canc Hosp, Zhengzhou, Peoples R China
[12] Shanghai Sixth Peoples Hosp, Shanghai, Peoples R China
[13] Zhejiang Univ, Dept Orthoped, Affiliated Hosp 2, Sch Med, Hangzhou, Peoples R China
[14] CSPC Pharmaceut Grp Ltd, Shanghai, Peoples R China
[15] CSPC Pharmaceut Grp Ltd, Beijing, Peoples R China
[16] AlaMab, Phoenixville, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11530
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Atezolizumab plus Bevacizumab in Patients with Unresectable or Metastatic Mucosal Melanoma: A Multicenter, Open-Label, Single-Arm Phase II Study
    Mao, Lili
    Fang, Meiyu
    Chen, Yu
    Wei, Xiaoting
    Cao, Jun
    Lin, Jing
    Zhang, Peng
    Chen, Ling
    Cao, Xiao
    Chen, Yujun
    Guo, Jun
    Si, Lu
    CLINICAL CANCER RESEARCH, 2022, 28 (21) : 4642 - 4648
  • [2] A single-arm, multicenter, open-label phase 2 trial of surufatinib in patients with unresectable or metastatic biliary tract cancer
    Xu, Jianming
    Bai, Yuxian
    Sun, Huichuan
    Bai, Chunmei
    Jia, Ru
    Li, Yi
    Zhang, Wenjie
    Liu, Lei
    Huang, Cheng
    Guan, Mei
    Zhou, Jinghong
    Su, Weiguo
    CANCER, 2021, 127 (21) : 3975 - 3984
  • [3] Atezolizumab plus bevacizumab in patients with unresectable or metastatic mucosal melanoma: A multicenter, open-label, single-arm phase 2 study.
    Mao, Lili
    Fang, Meiyu
    Chen, Yu
    Bai, Xue
    Cao, Jun
    Lin, Jing
    Zhang, Peng
    Chen, Ling
    Xu, Jiahui
    Guo, Jun
    Si, Lu
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [4] Tucidinostat plus toripalimab in patients with unresectable or metastatic melanoma: An open-label, single-arm phase II study
    Mao, Lili
    Dai, Jie
    Bai, Xue
    Kong, Yan
    Sheng, Xinan
    Chi, Zhihong
    Cui, Chuanliang
    Lian, Bin
    Tang, Bixia
    Yan, Xieqiao
    Wang, Xuan
    Li, Siming
    Zhou, Li
    Wei, Xiaoting
    Li, Juan
    Li, Caili
    Duan, Rong
    Xu, Huayan
    Guo, Jun
    Si, Lu
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [5] A single-arm, multicenter, open-label phase 2 trial of surufatinib in patients with unresectable or metastatic biliary tract cancer.
    Bai, Yuxian
    Xu, Jianming
    Sun, Huichuan
    Bai, Chunmei
    Jia, Ru
    Li, Yi
    Zhang, Wenjie
    Liu, Lei
    Huang, Cheng
    Guan, Mei
    Zhou, Jinghong
    Su, Weiguo
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [6] Safety and Efficacy of Apatinib Monotherapy for Unresectable, Metastatic Esophageal Cancer: A Single-Arm, Open-Label, Phase II Study
    Li Yanwei
    Feng, He
    Ren, Peng
    Yue, Jie
    Zhang, Wencheng
    Tang, Peng
    Shang, Xiaobin
    Pang, Qingsong
    Liu, Dongying
    Chen, Chuangui
    Pan, Zhanyu
    Tao, Yu Zhen
    ONCOLOGIST, 2020, 25 (10): : E1464 - E1472
  • [7] An open-label, single-arm study assessing safety and efficacy of panitumumab in patients with metastatic colorectal cancer refractory to standard chemotherapy
    Van Cutsem, E.
    Siena, S.
    Humblet, Y.
    Canon, J. -L.
    Maurel, J.
    Bajetta, E.
    Neyns, B.
    Kotasek, D.
    Santoro, A.
    Scheithauer, W.
    Spadafora, S.
    Amado, R. G.
    Hogan, N.
    Peeters, M.
    ANNALS OF ONCOLOGY, 2008, 19 (01) : 92 - 98
  • [8] Orelabrutinib for the treatment of relapsed or refractory MCL: a phase 1/2, open-label, multicenter, single-arm study
    Deng, Li-Juan
    Zhou, Ke-Shu
    Liu, Li-Hong
    Zhang, Ming-Zhi
    Li, Zhi-Ming
    Ji, Chun-Yan
    Xu, Wei
    Liu, Ting
    Xu, Bing
    Wang, Xin
    Gao, Su-Jun
    Zhang, Hui-Lai
    Hu, Yu
    Li, Yan
    Cheng, Ying
    Yang, Hai-Yan
    Cao, Jun-Ning
    Zhu, Zun-Min
    Hu, Jian-Da
    Zhang, Wei
    Jing, Hong-Mei
    Ding, Kai-Yang
    Zhang, Xiang-Yang
    Zhao, Ren -Bin
    Zhang, Bin
    Tian, Ya -Min
    Song, Yong-Ping
    Song, Yu-Qin
    Zhu, Jun
    BLOOD ADVANCES, 2023, 7 (16) : 4349 - 4357
  • [9] Tebotelimab, a PD1/LAG-3 bispecific antibody, in patients with untreated, unresectable, recurrent or metastatic, mucosal melanoma: An open-label, single-arm, Phase 1 study
    Lu, Si
    Chen, Yu
    Fang, Meiyu
    Zou, Zhengyun
    Wu, Di
    Luo, Zhiguo
    Zhang, Jian
    Chen, Jing
    Huang, Gang
    Pan, Hongming
    Ren, Xiubao
    Cheng, Ying
    Su, Haichuan
    Xin, Yuan
    Hua, Qiong
    Hou, Jianmei
    Guo, Jun
    CANCER RESEARCH, 2023, 83 (08)
  • [10] Efficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter Phase 3 Study
    Zager, Jonathan S.
    Orloff, Marlana
    Ferrucci, Pier Francesco
    Choi, Junsung
    Eschelman, David J.
    Glazer, Evan S.
    Ejaz, Aslam
    Howard, J. Harrison
    Richtig, Erika
    Ochsenreither, Sebastian
    Reddy, Sunil A.
    Lowe, Michael C.
    Beasley, Georgia M.
    Gesierich, Anja
    Bender, Armin
    Gschnell, Martin
    Dummer, Reinhard
    Rivoire, Michel
    Arance, Ana
    Fenwick, Stephen William
    Sacco, Joseph J.
    Haferkamp, Sebastian
    Weishaupt, Carsten
    John, Johnny
    Wheater, Matthew
    Ottensmeier, Christian H.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (08) : 5340 - 5351
12345